StonvexLoading…
StonvexStonvexStonvexCore line items from CHCO's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q3 2019 2019-09-30 | Q2 2019 2019-06-30 | Q1 2019 2019-03-31 | Q3 2018 2018-09-30 |
|---|---|---|---|---|
Revenue | $47.49M | $31.30M | $14.75M | $42.34M |
Operating Income | $28.76M | $28.77M | $27.64M | $26.48M |
Net Income | $22.37M | $22.75M | $21.62M | $20.69M |
EPS (Diluted) | $1.36 | $1.38 | $1.30 | $1.33 |
Total Assets | $4.96B | $4.94B | $4.92B | $4.42B |
Total Liabilities | $4.31B | $4.30B | $4.30B | $3.91B |
Cash & Equivalents | $116.19M | $168.72M | $143.85M | $305.91M |
Free Cash Flow OCF − CapEx | $72.84M | $45.40M | $18.49M | $51.60M |
Shares Outstanding | 16.29M | 16.39M | 16.43M | 15.36M |